GSK To Take Second Shot At The Rural Indian Market; Considering Customized Strategy
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India's largest multinational drug maker GlaxoSmithKline is planning a big entry into the country's rural pharmaceutical market. An exhaustive plan is being hammered out to understand the dynamics of the rural medicine market so that GSK can position itself correctly in the intensely price-sensitive market segment
You may also be interested in...
GSK India Managing Director Hasit Joshipura: An Interview With PharmAsia News (Part 2 of 2)
Joshipura discusses what lies ahead for India’s largest multinational drug company.
GSK India Managing Director Hasit Joshipura: An Interview With PharmAsia News (Part 2 of 2)
Joshipura discusses what lies ahead for India’s largest multinational drug company.
GSK India Managing Director Hasit Joshipura On What Lies Ahead For India’s Largest Multinational Drug Company: An Interview With PharmAsia News (Part 2 of 2)
GlaxoSmithKline India Managing Director Hasit Joshipura is known as one of the most aggressive multinational pharma directors in India in terms of expansion strategy. Some top GSK officials say he was brought in at the helm with the task of making GSK sharper in its marketing approach. Joshipura presented those capabilities in his earlier stint as the managing director at Johnson & Johnson India. Joshipura sat down with PharmAsia News' India bureau to discuss what lies ahead for India's largest multinational drug company.